VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ — Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed publication of the remarkable 5-year outcomes from its CE mark clinical […]
Tag: Implantica
Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success
VADUZ, Liechtenstein, July 1, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of treatment for acid reflux with its unique device RefluxStop®, a treatment field with 1 billion sufferers, announces the publication […]
Implantica announces new real-world Swiss study on 99 RefluxStop™ patients comparing small and large hiatal hernia, confirming equally excellent long-term results
VADUZ, Liechtenstein, June 12, 2025 /PRNewswire/ — Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a […]
Implantica publishes Interim Report January
VADUZ, Liechtenstein, May 9, 2025 /PRNewswire/ — Global expansion of RefluxStop™ Significant events in the first quarter of 2025 Received positive feedback from U.S. FDA on our Clinical Module 2 Premarket Approval (PMA) application. FDA […]
Implantica announces 15th RefluxStop™ Center in Spain
VADUZ, Liechtenstein, May 6, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a […]
